ABCELLERA BIOLOGICS (ABCL) insider trading activity (SEC Form 4). Over the trailing 90 days, ABCL insiders filed 4 purchases totalling $1.5M and 0 sales totalling $0 — net BUYING of $1.5M. Most recent filing: Aug 24, 2026. Insider transactions are a Pro-tier alertable signal in the live Top Tier Newswire terminal — Form 4 filings reach the wire within minutes of acceptance by the SEC. Data shown publicly here is delayed 4 hours.
| Filed | Insider | Role | Type | Shares | Price | Value | |
|---|---|---|---|---|---|---|---|
| Aug 24, 2026 | Hayden Michael R | Dir | P Purchase | — | $10.64 | $570K | filing |
| Aug 18, 2026 | Montalbano John S. | Dir | P Purchase | — | $11.03 | $110K | filing |
| Aug 14, 2026 | Booth Andrew | CFO | P Purchase | — | $10.32 | $384K | filing |
| Aug 14, 2026 | Hayden Michael R | Dir | P Purchase | — | $10.37 | $481K | filing |
| May 18, 2026 | Montalbano John S. | Dir | P Purchase | — | $4.77 | $95K | filing |